GlassScriptPhysician profile
Alexander Pei
NPI 1982153854
$1,767.20
in general payments reported to CMS, 2019-2025
12 companies · $596 in 2025
The $596 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $500 · 2022: $72.70 · 2023: $296 · 2024: $302 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $505.01 | 2021-2025 | Amvia Edge, Renamic Neo, Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $426.56 | 2021-2025 | Lifevest |
| Medtronic, INC. | $267.22 | 2021-2023 | Symplicity G3 |
| Edwards Lifesciences Corporation | $189.00 | 2024 | Sapien 3 Ultra Resilia |
| Amgen INC. | $146.74 | 2022-2023 | Repatha |
| Boston Scientific Corporation | $93.76 | 2024-2025 | General - Balloons |
| Actelion Pharmaceuticals US, INC. | $37.36 | 2024 | Opsumit |
| Cashflow Solutions, LLC | $23.97 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Teleflex LLC | $20.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.96 | 2023 | Jardiance |
| Elutia, INC. | $19.05 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Pei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.